Toyama Chemical Will Build A New Facility In Toyama City To Produce T-705
This article was originally published in PharmAsia News
Executive Summary
Toyama Chemical will expand its Toyama No.2 factory located in Toyama city and construct a facility to be used as a production site for T-705, a highly anticipated drug for treating avian influenza that is estimated to gain approval in Japan in 2009